Immunology
-
Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
This article has 22 authors:Reviewed by ScreenIT
-
Germinal center-derived broadly neutralizing antibodies adapt to SARS-CoV-2 antigenic drift
This article has 16 authors:Reviewed by ScreenIT
-
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19
This article has 19 authors:Reviewed by ScreenIT
-
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
This article has 24 authors:Reviewed by ScreenIT
-
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
This article has 10 authors:Reviewed by ScreenIT
-
Cytotoxic T Lymphocytes Targeting a Conserved SARS-CoV-2 Spike Epitope are Efficient Serial Killers
This article has 5 authors:Reviewed by ScreenIT
-
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
This article has 15 authors:Reviewed by ScreenIT
-
Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
This article has 15 authors:Reviewed by ScreenIT
-
Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants
This article has 2 authors:Reviewed by ScreenIT
-
Forecasted Trends of the New COVID-19 Epidemic Due to the Omicron Variant in Thailand, 2022
This article has 5 authors:Reviewed by ScreenIT